Baylor College of Medicine: Infections trials

The registry lists 13 Infections studies with Baylor College of Medicine as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 1 5Phase 2 2Phase 3 1Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy of ActiveMatrix on Spinal SSI RateNot yet recruitingNCT05297513Phase 4
• Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract InfectionTerminatedNCT02198833Not applicableResults posted
• Efficacy Study of Antiseptic Preoperative Scrubs in Prevention of Postoperative InfectionsCompletedNCT00290290Phase 3Results posted
• Diagnostic Utility of Otosight Middle Ear ScopeActive, not recruitingNCT05641285
• Catheter Biofilm Microbiome in Infected Neonatal Catheters.CompletedNCT01985737
• Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)No longer availableNCT01945619
• Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)CompletedNCT01070797Phase 1
• Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and AdenovirusCompletedNCT00880789Phase 1
• Probiotics for Girls With Recurring Urinary Tract InfectionsWithdrawnNCT00789464Phase 2
• Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)CompletedNCT00711035Phase 1/2
• Prevention of Urinary Tract Infection (UTI) in Persons With Spinal Cord Injury (SCI)CompletedNCT00309114Not applicable
• Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm InfectionCompletedNCT00120081Phase 1
• Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)CompletedNCT00058591Phase 1